1. Home
  2. VKTX vs WHD Comparison

VKTX vs WHD Comparison

Compare VKTX & WHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • WHD
  • Stock Information
  • Founded
  • VKTX 2012
  • WHD 2011
  • Country
  • VKTX United States
  • WHD United States
  • Employees
  • VKTX N/A
  • WHD N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • WHD Metal Fabrications
  • Sector
  • VKTX Health Care
  • WHD Industrials
  • Exchange
  • VKTX Nasdaq
  • WHD Nasdaq
  • Market Cap
  • VKTX 3.4B
  • WHD 3.9B
  • IPO Year
  • VKTX 2015
  • WHD 2018
  • Fundamental
  • Price
  • VKTX $23.94
  • WHD $37.81
  • Analyst Decision
  • VKTX Strong Buy
  • WHD Hold
  • Analyst Count
  • VKTX 12
  • WHD 6
  • Target Price
  • VKTX $89.75
  • WHD $53.80
  • AVG Volume (30 Days)
  • VKTX 4.5M
  • WHD 1.2M
  • Earning Date
  • VKTX 04-23-2025
  • WHD 04-30-2025
  • Dividend Yield
  • VKTX N/A
  • WHD 1.38%
  • EPS Growth
  • VKTX N/A
  • WHD 7.91
  • EPS
  • VKTX N/A
  • WHD 2.77
  • Revenue
  • VKTX N/A
  • WHD $1,129,814,000.00
  • Revenue This Year
  • VKTX N/A
  • WHD $1.34
  • Revenue Next Year
  • VKTX N/A
  • WHD $5.85
  • P/E Ratio
  • VKTX N/A
  • WHD $13.63
  • Revenue Growth
  • VKTX N/A
  • WHD 3.00
  • 52 Week Low
  • VKTX $18.92
  • WHD $33.80
  • 52 Week High
  • VKTX $81.86
  • WHD $70.01
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 46.06
  • WHD 37.69
  • Support Level
  • VKTX $18.92
  • WHD $36.05
  • Resistance Level
  • VKTX $27.09
  • WHD $37.69
  • Average True Range (ATR)
  • VKTX 2.31
  • WHD 2.75
  • MACD
  • VKTX 0.26
  • WHD -0.02
  • Stochastic Oscillator
  • VKTX 61.44
  • WHD 29.27

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control , which generates key revenue and Spoolable Technologies.

Share on Social Networks: